Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on July 1, 2026

Jul. 1, 2026

Berto Acquisition Corp. II Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing on or about July 6, 2026

Indeterminate GlobeNewswire

Jul. 1, 2026

RTX Holders Told To Register Wallets As Remittix Airdrop Page Goes Live

Indeterminate GlobeNewswire

Jul. 1, 2026

Wikitree Selects DeeperDive From Taboola, Gen AI Answer Engine Built for the Open Web, to Connect Readers with Timely, Contextual Answers for Topics They Care About

Indeterminate GlobeNewswire

Jul. 1, 2026

MathCo Expands Databricks Center of Excellence to Help Retail and CPG Enterprises Operationalize Agentic AI

Indeterminate GlobeNewswire

Jul. 1, 2026

Rethink Food and Just Salad Roll Out Rethink Food Bowl for July

Indeterminate GlobeNewswire

Jul. 1, 2026

Mom’s Choice Awards Names Raddish Kids Cooking & Baking Subscription Boxes Among the Best in Family-Friendly Products

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba has received marketing authorization in France for its biofungicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax announces trading resumption of its ordinary shares on Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris

Indeterminate GlobeNewswire

Jul. 1, 2026

Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform

Indeterminate GlobeNewswire

Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

Indeterminate GlobeNewswire

Jul. 1, 2026

Artelo Biosciences Announces New Data Supporting ART26.12 as a Potential First-in-Class Therapy for Chronic Pain associated with Spinal Cord Injury

Indeterminate GlobeNewswire

Jul. 1, 2026

QTREX Engineers Conductivity Itself to Address Quantum Computing’s Cryogenic Heat-Load Barrier

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares

Indeterminate GlobeNewswire

Jul. 1, 2026

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares

Indeterminate GlobeNewswire